Investec Bank Plc has filed a Form 8.5 disclosure under Rule 8.5 of the Takeover Code regarding dealings in Advanced Medical Solutions Group Plc (AMS.L) shares.
The disclosure, dated 21st September 2026, covers transactions undertaken on 18th September 2026 in the ordinary shares of Advanced Medical Solutions Group Plc.
Investec Bank Plc is acting as Advisor and Joint Broker to Advanced Medical Solutions Group Plc in connection with the relevant offer.
The filing identifies Investec as an exempt principal trader with recognised intermediary status, dealing in a client-serving capacity under the Takeover Code framework.
In terms of purchases, Investec Bank Plc acquired 35,703 ordinary shares, with prices ranging from a low of 281.5p to a high of 282p per unit.
On the sales side, the bank disposed of 515,471 ordinary shares, again within the same price range of 281.5p to 282p per unit.
The volume disparity between purchases and sales reflects the nature of client-serving market-making activity that exempt principal traders typically conduct during offer periods.
Investec confirmed that no cash-settled derivative transactions, stock-settled derivative transactions, or other dealings such as subscriptions or conversions took place on the relevant date.
The disclosure also confirms that no indemnity arrangements, options, or agreements relating to voting rights or future acquisitions of relevant securities were in place at the time of the filing.
Public disclosures of this nature under Rule 8 of the Takeover Code are required to be submitted to a Regulatory Information Service, ensuring full transparency during offer periods.
The contact named in the filing is Priyali Bhattacharjee, reachable by telephone, with the disclosure date formally recorded as 21st September 2026.
Advanced Medical Solutions Group Plc trades on the London Stock Exchange under the ticker AMS.L, and regulatory filings of this kind are standard procedure whenever a connected intermediary conducts market dealings during a takeover process.
